世界のプロスタグランジンE2受容体EP4サブタイプ市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Prostaglandin E2 Receptor EP4 Subtype Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5967
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、プロスタグランジンE2受容体EP4サブタイプの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（E-7046、ER-886046、グラピプラント、KAG-308、ONO-4232、その他）、用途別市場規模（乳がん、アレルギー、慢性痛、急性痛、肺がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・プロスタグランジンE2受容体EP4サブタイプの市場動向
・企業の競争状況、市場シェア
・プロスタグランジンE2受容体EP4サブタイプの種類別市場規模と予測2016-2027（E-7046、ER-886046、グラピプラント、KAG-308、ONO-4232、その他）
・プロスタグランジンE2受容体EP4サブタイプの用途別市場規模と予測2016-2027（乳がん、アレルギー、慢性痛、急性痛、肺がん、その他）
・プロスタグランジンE2受容体EP4サブタイプの北米市場規模2016-2027（アメリカ、カナダ）
・プロスタグランジンE2受容体EP4サブタイプの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・プロスタグランジンE2受容体EP4サブタイプのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・プロスタグランジンE2受容体EP4サブタイプの中南米市場規模2016-2027（メキシコ、ブラジル）
・プロスタグランジンE2受容体EP4サブタイプの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Eisai Co Ltd、Eli Lilly and Co、Kaken Pharmaceutical Co Ltd、Ono Pharmaceutical Co Ltd、RaQualia Pharma Inc、Rottapharm Biotech Srl）
・結論

Market Analysis and Insights: Global Prostaglandin E2 Receptor EP4 Subtype Market
The global Prostaglandin E2 Receptor EP4 Subtype market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostaglandin E2 Receptor EP4 Subtype market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostaglandin E2 Receptor EP4 Subtype market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostaglandin E2 Receptor EP4 Subtype market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostaglandin E2 Receptor EP4 Subtype market.

Global Prostaglandin E2 Receptor EP4 Subtype Scope and Market Size
Prostaglandin E2 Receptor EP4 Subtype market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostaglandin E2 Receptor EP4 Subtype market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
E-7046
ER-886046
Grapiprant
KAG-308
ONO-4232
Others

Segment by Application
Breast Cancer
Allergies
Chronic Pain
Acute Pain
Lung Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eisai Co Ltd
Eli Lilly and Co
Kaken Pharmaceutical Co Ltd
Ono Pharmaceutical Co Ltd
RaQualia Pharma Inc
Rottapharm Biotech Srl

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 E-7046
1.2.3 ER-886046
1.2.4 Grapiprant
1.2.5 KAG-308
1.2.6 ONO-4232
1.2.7 Others
1.3 Market by Application
1.3.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Allergies
1.3.4 Chronic Pain
1.3.5 Acute Pain
1.3.6 Lung Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Perspective (2016-2027)
2.2 Prostaglandin E2 Receptor EP4 Subtype Growth Trends by Regions
2.2.1 Prostaglandin E2 Receptor EP4 Subtype Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prostaglandin E2 Receptor EP4 Subtype Historic Market Share by Regions (2016-2021)
2.2.3 Prostaglandin E2 Receptor EP4 Subtype Forecasted Market Size by Regions (2022-2027)
2.3 Prostaglandin E2 Receptor EP4 Subtype Industry Dynamic
2.3.1 Prostaglandin E2 Receptor EP4 Subtype Market Trends
2.3.2 Prostaglandin E2 Receptor EP4 Subtype Market Drivers
2.3.3 Prostaglandin E2 Receptor EP4 Subtype Market Challenges
2.3.4 Prostaglandin E2 Receptor EP4 Subtype Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Prostaglandin E2 Receptor EP4 Subtype Players by Revenue
3.1.1 Global Top Prostaglandin E2 Receptor EP4 Subtype Players by Revenue (2016-2021)
3.1.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Players (2016-2021)
3.2 Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prostaglandin E2 Receptor EP4 Subtype Revenue
3.4 Global Prostaglandin E2 Receptor EP4 Subtype Market Concentration Ratio
3.4.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostaglandin E2 Receptor EP4 Subtype Revenue in 2020
3.5 Prostaglandin E2 Receptor EP4 Subtype Key Players Head office and Area Served
3.6 Key Players Prostaglandin E2 Receptor EP4 Subtype Product Solution and Service
3.7 Date of Enter into Prostaglandin E2 Receptor EP4 Subtype Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Prostaglandin E2 Receptor EP4 Subtype Breakdown Data by Type
4.1 Global Prostaglandin E2 Receptor EP4 Subtype Historic Market Size by Type (2016-2021)
4.2 Global Prostaglandin E2 Receptor EP4 Subtype Forecasted Market Size by Type (2022-2027)

5 Prostaglandin E2 Receptor EP4 Subtype Breakdown Data by Application
5.1 Global Prostaglandin E2 Receptor EP4 Subtype Historic Market Size by Application (2016-2021)
5.2 Global Prostaglandin E2 Receptor EP4 Subtype Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Prostaglandin E2 Receptor EP4 Subtype Market Size (2016-2027)
6.2 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type
6.2.1 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2021)
6.2.2 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2022-2027)
6.2.3 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2027)
6.3 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application
6.3.1 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2016-2021)
6.3.2 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2022-2027)
6.3.3 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2016-2027)
6.4 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country
6.4.1 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2016-2021)
6.4.2 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size (2016-2027)
7.2 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Type
7.2.1 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2021)
7.2.2 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2022-2027)
7.2.3 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2027)
7.3 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Application
7.3.1 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2016-2021)
7.3.2 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2022-2027)
7.3.3 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2016-2027)
7.4 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Country
7.4.1 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2016-2021)
7.4.2 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size (2016-2027)
8.2 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Type
8.2.1 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2027)
8.3 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Application
8.3.1 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2016-2027)
8.4 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Region
8.4.1 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size (2016-2027)
9.2 Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type
9.2.1 Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2021)
9.2.2 Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2022-2027)
9.2.3 Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2027)
9.3 Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application
9.3.1 Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2016-2021)
9.3.2 Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2022-2027)
9.3.3 Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2016-2027)
9.4 Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country
9.4.1 Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2016-2021)
9.4.2 Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size (2016-2027)
10.2 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Type
10.2.1 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2027)
10.3 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Application
10.3.1 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2016-2027)
10.4 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Country
10.4.1 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eisai Co Ltd
11.1.1 Eisai Co Ltd Company Details
11.1.2 Eisai Co Ltd Business Overview
11.1.3 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Introduction
11.1.4 Eisai Co Ltd Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021)
11.1.5 Eisai Co Ltd Recent Development
11.2 Eli Lilly and Co
11.2.1 Eli Lilly and Co Company Details
11.2.2 Eli Lilly and Co Business Overview
11.2.3 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Introduction
11.2.4 Eli Lilly and Co Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021)
11.2.5 Eli Lilly and Co Recent Development
11.3 Kaken Pharmaceutical Co Ltd
11.3.1 Kaken Pharmaceutical Co Ltd Company Details
11.3.2 Kaken Pharmaceutical Co Ltd Business Overview
11.3.3 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Introduction
11.3.4 Kaken Pharmaceutical Co Ltd Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021)
11.3.5 Kaken Pharmaceutical Co Ltd Recent Development
11.4 Ono Pharmaceutical Co Ltd
11.4.1 Ono Pharmaceutical Co Ltd Company Details
11.4.2 Ono Pharmaceutical Co Ltd Business Overview
11.4.3 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Introduction
11.4.4 Ono Pharmaceutical Co Ltd Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021)
11.4.5 Ono Pharmaceutical Co Ltd Recent Development
11.5 RaQualia Pharma Inc
11.5.1 RaQualia Pharma Inc Company Details
11.5.2 RaQualia Pharma Inc Business Overview
11.5.3 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Introduction
11.5.4 RaQualia Pharma Inc Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021)
11.5.5 RaQualia Pharma Inc Recent Development
11.6 Rottapharm Biotech Srl
11.6.1 Rottapharm Biotech Srl Company Details
11.6.2 Rottapharm Biotech Srl Business Overview
11.6.3 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Introduction
11.6.4 Rottapharm Biotech Srl Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021)
11.6.5 Rottapharm Biotech Srl Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of E-7046
Table 3. Key Players of ER-886046
Table 4. Key Players of Grapiprant
Table 5. Key Players of KAG-308
Table 6. Key Players of ONO-4232
Table 7. Key Players of Others
Table 8. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Regions (2016-2021)
Table 12. Global Prostaglandin E2 Receptor EP4 Subtype Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Regions (2022-2027)
Table 14. Prostaglandin E2 Receptor EP4 Subtype Market Trends
Table 15. Prostaglandin E2 Receptor EP4 Subtype Market Drivers
Table 16. Prostaglandin E2 Receptor EP4 Subtype Market Challenges
Table 17. Prostaglandin E2 Receptor EP4 Subtype Market Restraints
Table 18. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Players (2016-2021)
Table 20. Global Top Prostaglandin E2 Receptor EP4 Subtype Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostaglandin E2 Receptor EP4 Subtype as of 2020)
Table 21. Ranking of Global Top Prostaglandin E2 Receptor EP4 Subtype Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Prostaglandin E2 Receptor EP4 Subtype Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Prostaglandin E2 Receptor EP4 Subtype Product Solution and Service
Table 25. Date of Enter into Prostaglandin E2 Receptor EP4 Subtype Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2016-2021)
Table 29. Global Prostaglandin E2 Receptor EP4 Subtype Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2016-2021)
Table 33. Global Prostaglandin E2 Receptor EP4 Subtype Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2022-2027) & (US$ Million)
Table 65. Eisai Co Ltd Company Details
Table 66. Eisai Co Ltd Business Overview
Table 67. Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product
Table 68. Eisai Co Ltd Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021) & (US$ Million)
Table 69. Eisai Co Ltd Recent Development
Table 70. Eli Lilly and Co Company Details
Table 71. Eli Lilly and Co Business Overview
Table 72. Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Product
Table 73. Eli Lilly and Co Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021) & (US$ Million)
Table 74. Eli Lilly and Co Recent Development
Table 75. Kaken Pharmaceutical Co Ltd Company Details
Table 76. Kaken Pharmaceutical Co Ltd Business Overview
Table 77. Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product
Table 78. Kaken Pharmaceutical Co Ltd Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021) & (US$ Million)
Table 79. Kaken Pharmaceutical Co Ltd Recent Development
Table 80. Ono Pharmaceutical Co Ltd Company Details
Table 81. Ono Pharmaceutical Co Ltd Business Overview
Table 82. Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product
Table 83. Ono Pharmaceutical Co Ltd Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021) & (US$ Million)
Table 84. Ono Pharmaceutical Co Ltd Recent Development
Table 85. RaQualia Pharma Inc Company Details
Table 86. RaQualia Pharma Inc Business Overview
Table 87. RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Product
Table 88. RaQualia Pharma Inc Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021) & (US$ Million)
Table 89. RaQualia Pharma Inc Recent Development
Table 90. Rottapharm Biotech Srl Company Details
Table 91. Rottapharm Biotech Srl Business Overview
Table 92. Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Product
Table 93. Rottapharm Biotech Srl Revenue in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021) & (US$ Million)
Table 94. Rottapharm Biotech Srl Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Type: 2020 VS 2027
Figure 2. E-7046 Features
Figure 3. ER-886046 Features
Figure 4. Grapiprant Features
Figure 5. KAG-308 Features
Figure 6. ONO-4232 Features
Figure 7. Others Features
Figure 8. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Application: 2020 VS 2027
Figure 9. Breast Cancer Case Studies
Figure 10. Allergies Case Studies
Figure 11. Chronic Pain Case Studies
Figure 12. Acute Pain Case Studies
Figure 13. Lung Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Prostaglandin E2 Receptor EP4 Subtype Report Years Considered
Figure 16. Global Prostaglandin E2 Receptor EP4 Subtype Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Prostaglandin E2 Receptor EP4 Subtype Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Regions: 2020 VS 2027
Figure 19. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Regions (2022-2027)
Figure 20. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Players in 2020
Figure 21. Global Top Prostaglandin E2 Receptor EP4 Subtype Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostaglandin E2 Receptor EP4 Subtype as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Prostaglandin E2 Receptor EP4 Subtype Revenue in 2020
Figure 23. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2016-2021)
Figure 24. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2022-2027)
Figure 25. North America Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Prostaglandin E2 Receptor EP4 Subtype Market Share by Type (2016-2027)
Figure 27. North America Prostaglandin E2 Receptor EP4 Subtype Market Share by Application (2016-2027)
Figure 28. North America Prostaglandin E2 Receptor EP4 Subtype Market Share by Country (2016-2027)
Figure 29. United States Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Prostaglandin E2 Receptor EP4 Subtype Market Share by Type (2016-2027)
Figure 33. Europe Prostaglandin E2 Receptor EP4 Subtype Market Share by Application (2016-2027)
Figure 34. Europe Prostaglandin E2 Receptor EP4 Subtype Market Share by Country (2016-2027)
Figure 35. Germany Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Share by Region (2016-2027)
Figure 45. China Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Prostaglandin E2 Receptor EP4 Subtype Market Share by Type (2016-2027)
Figure 53. Latin America Prostaglandin E2 Receptor EP4 Subtype Market Share by Application (2016-2027)
Figure 54. Latin America Prostaglandin E2 Receptor EP4 Subtype Market Share by Country (2016-2027)
Figure 55. Mexico Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Share by Country (2016-2027)
Figure 61. Turkey Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Prostaglandin E2 Receptor EP4 Subtype Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Eisai Co Ltd Revenue Growth Rate in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021)
Figure 65. Eli Lilly and Co Revenue Growth Rate in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021)
Figure 66. Kaken Pharmaceutical Co Ltd Revenue Growth Rate in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021)
Figure 67. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021)
Figure 68. RaQualia Pharma Inc Revenue Growth Rate in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021)
Figure 69. Rottapharm Biotech Srl Revenue Growth Rate in Prostaglandin E2 Receptor EP4 Subtype Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Global Prostaglandin E2 Receptor EP2 Subtype Market Size, Status and Forecast 2021-2027
QFJ1-5966 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、プロスタグランジンE2受容体EP2サブタイプの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（TG-4155、SAR-366234、ONO-8055、トレプロスチニル、その他）、用途別市場規模（クリニッ...

世界のインターロイキン12受容体市場規模・現状・予測（2021年-2027年）

Global Interleukin 12 Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5806 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、インターロイキン12受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エドデキンアルファSR、M-9241、LY-3232094、NMIL-121、その他）、用途別市場規模（入院患者、外来患者）、...

世界のC-X-Cケモカイン受容体タイプ1市場規模・現状・予測（2021年-2027年）

Global C-X-C Chemokine Receptor Type 1 Market Size, Status and Forecast 2021-2027
QFJ1-5683 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、C-X-Cケモカイン受容体タイプ1の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（DF-2755A、PAC-G31P、レパリキシン、SX-576、その他）、用途別市場規模（炎症、肺がん、黒色腫、術後痛...

世界のエフリンB型受容体4市場規模・現状・予測（2021年-2027年）

Global Ephrin Type B Receptor 4 Market Size, Status and Forecast 2021-2027
QFJ1-5725 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、エフリンB型受容体4の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（VDAU-11、Vas-01、トシレートテセバチニブ、その他）、用途別市場規模（固形腫瘍、胆管がん、結腸直腸がん、黒色腫、その他）、...

世界のN-ホルミルペプチド受容体2市場規模・現状・予測（2021年-2027年）

Global N-Formyl Peptide Receptor 2 Market Size, Status and Forecast 2021-2027
QFJ1-5886 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、N-ホルミルペプチド受容体2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（TR-8、NCP-70X、ヒューマニン、その他）、用途別市場規模（炎症、2型糖尿病、アレルギー、脳虚血、転移性がん、その他）...

世界のブラジキニンB1受容体市場規模・現状・予測（2021年-2027年）

Global Bradykinin B1 Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5635 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、ブラジキニンB1受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（BI-113823、その他）、用途別市場規模（診療所、病院、家庭用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界のGLP-1受容体アゴニスト市場規模・現状・予測（2021年-2027年）

Global GLP-1 Receptor Agonists Market Size, Status and Forecast 2021-2027
QFJ1-4259 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、GLP-1受容体アゴニストの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エクセナチド、リラグルチド、リキシセナチド、アルビグルチド、その他）、用途別市場規模（固形腫瘍、血液関連腫瘍）、主要地域別市場...

世界のα2Cアドレナリン受容体市場規模・現状・予測（2021年-2027年）

Global Alpha 2C Adrenergic Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5572 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、α2Cアドレナリン受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ラクリペップ、JNJ-4789、SKL-PSY、その他）、用途別市場規模（双極性障害、ドライアイ、大うつ病、その他）、主要地域別...

世界のトロンボポエチン受容体市場規模・現状・予測（2021年-2027年）

Global Thrombopoietin Receptor Market Size, Status and Forecast 2021-2027
QFJ1-6039 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、トロンボポエチン受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エルトロンボパグオラミン、GSK-2285921、ロミプロスティム、STST-4、その他）、用途別市場規模（クリニック、病院、その...

世界のC-X-Cケモカイン受容体タイプ2市場規模・現状・予測（2021年-2027年）

Global C-X-C Chemokine Receptor Type 2 Market Size, Status and Forecast 2021-2027
QFJ1-5684 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、C-X-Cケモカイン受容体タイプ2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（DF-2755A、AZD-5069、PAC-G31P、SX-517、その他）、用途別市場規模（冠状動脈疾患、肝移植拒絶...

世界のプロスタグランジンE2受容体EP2サブタイプ市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Prostaglandin E2 Receptor EP2 Subtype Market The global Prostaglandin E2 Receptor EP2 Subtype market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
世界のC-X-Cケモカイン受容体タイプ1市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global C-X-C Chemokine Receptor Type 1 Market The global C-X-C Chemokine Receptor Type 1 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
世界の上皮成長因子受容体（EGFR）阻害剤市場規模・現状・予測（2021年-2027年） The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands. The high efficacy of EGFR inhibitors in the treatment of various types of cancer indicati…
世界のチロシンプロテインキナーゼ受容体TYRO3市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tyrosine Protein Kinase Receptor TYRO3 Market The global Tyrosine Protein Kinase Receptor TYRO3 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…
世界のN-ホルミルペプチド受容体2市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global N-Formyl Peptide Receptor 2 Market The global N-Formyl Peptide Receptor 2 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…